News archives

Home > News archives

No opposition filed against NBHL’s European patent for anti-CCR7 antibodies

Apr 22,2020 -- Updated 14:33 +0900 (GMT)

We are informed by European Patent Office that on expiry of the opposition period no notice of opposition has been filed against the NBHL’s European patent for anti-CCR7 antibodies granted in 2019. 

Title of the invention: Anti-human CCR7 antibodies, hybridoma, medical composition, and antibody-immobilized carrier

Patent number: EP 2 623 592

Application number: 11829086.5

Proprietor: NB Health Laboratory Co. Ltd.

 CCR7 is a GPCR involved in the pathogenesis of fibrosis and cancer. We will continue to proceed with the development of therapeutic anti-CCR7 antibodies.

NBHL announces poster presentation at Antibody Engineering & Therapeutics Asia 2020 in Kyoto, Japan

Feb 24,2020 -- Updated 09:00 +0900 (GMT)

Kiyoshi Takayama (President, NBHL) will have a poster presentation at Antibody Engineering & Therapeutics Asia 2020 to be held in The Westin Miyako Kyoto, Japan, from February 24th to 26th, 2020. Our presentation will focus on the new MoGRAA® discovery engine powered by the innovative high-throughput single-cell technology RiGRASSTM for discovering functional anti-GPCR antibodies. Please stop by our poster, and we look forward to meeting you to discuss future collaboration opportunities.

 

[URL]

https://informaconnect.com/antibody-engineering-therapeutics-asia/

 

NBHL will attend BIO CEO & Investor Conference 2020 in New York, USA

Feb 6,2020 -- Updated 15:16 +0900 (GMT)

NBHL will be at the BIO CEO & Investor Conference 2020 to be held in New York from February 10th to 11th, 2020. NBHL’s Business Development team will attend this exciting event. We are looking forward to meeting you in New York to discuss future opportunities.

 

For more information on this event, please visit https://www.bio.org/events/bio-ceo-investor-conference

NBHL to present at Antibody Engineering & Therapeutics 2019 in San Diego, USA

Dec 6,2019 -- Updated 10:57 +0900 (GMT)

Kiyoshi Takayama (President, NBHL) will give a presentation at Antibody Engineering & Therapeutics 2019 to be held in San Diego, USA, from December 9th to 13th, 2019. His talk will focus on the innovative high-throughput single-cell technology RiGRASSTM for the discovery of functional anti-GPCR antibodies.

 [Date of Presentation]

 December 11th, 2019 (2:55 pm – 3:25 pm)

 [Venue]

 Marriott Marquis San Diego

 [Session]

 Track 1: Emerging Technologies and Approaches for Antibody Engineering

 [Presentation Title]

 Discovery of Therapeutic Functional mAbs Targeting GPCR with a Unique Single Cell Analysis Technique

 [URL]

 https://lifesciences.knect365.com/antibody-engineering-therapeutics/

NBHL will attend BIO-Europe 2019 in Hamburg, Germany.

Nov 8,2019 -- Updated 09:47 +0900 (GMT)

NBHL will be at “BIO-Europe 2019” to be held in Hamburg, Germany, from November 11th to 13th, 2019. Kiyoshi Takayama (President, NBHL) and our Business Development team will attend this exciting event and would like to meet you there.

For more information on this event, please visit https://ebdgroup.knect365.com/bioeurope/

NBHL will attend BIO Investor Forum 2019 in San Francisco, USA

Oct 21,2019 -- Updated 18:00 +0900 (GMT)

NBHL will be at the BIO Investor Forum 2019 to be held in San Francisco from October 22nd to 23rd, 2019. Kiyoshi Takayama (President, NBHL) and our Business Development team will attend this exciting event. We will make a short presentation on the new MoGRAA® discovery engine powered by the innovative high-throughput single-cell technology RiGRASSTM for discovering anti-GPCR antibodies and our antibody pipelines. This presentation is scheduled from 3:15 to 3:30 pm on October 22nd. We are looking forward to meeting you in San Francisco to discuss future opportunities. 

For more information on this event, please visit https://www.bio.org/events/bio-investor-forum

 

NBHL to present at the FESTIVAL OF BIOLOGICS 2019 in Basel, Switzerland

Oct 15,2019 -- Updated 10:23 +0900 (GMT)

Kiyoshi Takayama (President, NBHL) will give a presentation at the FESTIVAL OF BIOLOGICS 2019 to be held in Basel, Switzerland, from October 15th to 17th, 2019. He will chair the Technology Showcase session on October 15th. Looking forward to meeting you in Basel to discuss future opportunities.

[Date of Presentation]

October 16th, 2019 (Start time: 11:25 am)

[Venue]

Basel Congress Centre

[Session]

Technology Showcase

[Presentation Title]

MoGRAA® discovery engine to generate the functional therapeutic mAbs targeting GPCRs with a unique single cell analysis technique

[URL]

https://www.terrapinn.com/conference/festival-of-biologics/index.stm

 

NBHL will be present at BioJapan 2019 in Yokohama, Japan

Oct 8,2019 -- Updated 17:22 +0900 (GMT)

NBHL will have a panel exhibition at C-06 (in Hokkaido Bio Cluster booth) in “BioJapan 2019” to be held in Pacifico Yokohama, Japan, from October 9th to 11th, 2019. Kiyoshi Takayama (CEO, NBHL) will make a short presentation on “RiGRASSTMan innovative high-throughput single-cell technology for discovering anti-GPCR antibodies.” This presentation is scheduled at Exhibitor’s Stage I from 14:35 to 14:45 on October 11th. We are looking forward to meeting you in Yokohama.

For more information on this event, please visit https://www.ics-expo.jp/biojapan/en/

 

NBHL will attend Discovery on Target 2019 in Boston, USA.

Sep 11,2019 -- Updated 17:30 +0900 (GMT)

NBHL will be at Discovery on Target 2019 to be held in Boston from September 16th to 19th, 2019. Kiyoshi Takayama (President, NBHL) will make a poster presentation on our new single-cell technology for GPCR antibody production.

 NB Health Laboratory Co. Ltd.

Poster #164. Discovery of the Functional Therapeutic mAbs Targeting GPCRs with a Unique Single Cell Analysis Technique

 For more information on this event, please visit https://www.discoveryontarget.com/

 

NBHL will attend 2019 BIO International Convention in Philadelphia, USA.

May 28,2019 -- Updated 17:16 +0900 (GMT)

NBHL will be at “2019 BIO International Convention” to be held in Philadelphia from June 3rd to 6th, 2019. Kiyoshi Takayama (President, NBHL) and our Business Development team will attend this exciting event. Please visit our booth located in Japan Pavilion(booth #1509). We are looking forward to meeting you in Philadelphia to discuss future opportunities.

 

For more information on this event, please visit  <https://convention.bio.org/2019/>

次へ »